CORONAVIRUS COVID-19: AVAILABLE FREE LITERATURE PROVIDED BY VARIOUS COMPANIES, JOURNALS AND ORGANIZATIONS AROUND THE WORLD

Human history is observing a very strange time fighting an invisible enemy; the novel COVID-19 coronavirus. Initially observed in the Wuhan province of China, now fastly spreading around the world. Various journals are offering to freely publish the articles about Coronavirus. As this pandemic is very new and very less scientific material is available on the topic, various paid journals and companies are offering free materials published about the Coronavirus. Here in this short review, we will discuss the articles about Coronavirus that are freely provided by various journals and companies around the world. This review is open to updates. If you find some more free resources available, let us know at info@scimatic.org to update. Infectious Disease Research - on infectious diseases including coronavirus, SARS, MERS and Ebola Interdisciplinary Coronavirus & Infectious Disease Related Research - related to public health, legal, economic, societal and fiscal implications

. The rise of deaths and active cases of Coronavirus Various journals are offering to publish your articles for free about Coronavirus. Here in this short review, we will discuss the articles about Coronavirus that are freely provided by various journals and companies.

American Chemical Society (ACS)
ACS is providing various articles published in the ACS Infectious Diseases, ACS Chemical Biology, Journal of Medicinal Chemistry, Biochemistry, Chemical Reviews, and ACS Applied Materials & Interfaces as well as the preprint server ChemRxiv. These articles can be accessed from the link below: https://pubs.acs.org/page/vi/chemistry_coronavirus_res earch?utm_source=pubs_content_marketing&utm_me dium=email&utm_campaign=0320_MFH_PUBS_032 0_MFH_CoronavirusSecondEmail&ref=pubs_content _marketing These articles are explained in the below lines.

Characterizing virus structure and mechanism of infection
Multiplex Paper-Based Colorimetric DNA Sensor Using 1.
Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms [Baig et al, 2020] Research and Development on Therapeutic Agents and 3.

Development of treatment approaches
Broad Spectrum Antiviral Agent Niclosamide and Its 1.
Protein-Protein Interactions of Coronavirus Nucleocapsid Proteins in Antiviral Drug Design [Lin et al, 2020] α-Ketoamides as Broad-Spectrum Inhibitors of 3.
Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment [Zhang, 2020] Integration of Global Analyses of Host Molecular 4.
Responses with Clinical Data To Evaluate Pathogenesis and Advance Therapies for Emerging and Re-emerging Viral Infections [Falcinelli et al, 2016] An Overview of Severe Acute Respiratory 5.
Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors  Design, Synthesis, and Anti-RNA Virus Activity of 6′-7.
Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery  Combating Intracellular Pathogens with Repurposed Host-9.
Challenges [Malonis et al, 2019] The ProTide Prodrug Technology: From the Concept to the 11.
Diseases [Rao et al, 2020 In response to the COVID-19 pandemic, the Allen Institute for AI has partnered with leading research groups to prepare and distribute the COVID-19 Open Research Dataset (CORD-19), a free resource of over 44,000 scholarly articles, including over 29,000 with full text, about COVID-19 and the coronavirus family of viruses for use by the global research community.
This dataset is intended to mobilize researchers to apply recent advances in natural language processing to generate new insights in support of the fight against this infectious disease. The corpus will be updated weekly as new research is published in peer-reviewed publications and archival services like bioRxiv, medRxiv, and others.

World Health Organization (WHO)
WHO is gathering the latest scientific findings and knowledge on coronavirus disease (COVID-19) and compiling it in a database. We update the database daily from searches of bibliographic databases, hand searches of the  Additionally, BMJ also provides BMJ's clinical decision support tool and Interactive, peer reviewed learning modules from BMJ.

Cambridge University Press
Cambridge University Press has started a Coronavirus Free Access Collection at https://www.cambridge.org/core/browse-subjects/m edicine/coronavirus-free-access-collection. They have 133 articles on 21 st March, 2020.

Centers for Disease Control and Prevention
The Center of Disease Control (CDC) and Prevention belong to the government of United States has started a separate page entitled Coronavirus (COVID-19). The page is live at https://www.cdc.gov/coronavirus/2019-ncov/index.h tml. This page provides the details about how to protect yourself, if you think you are sick, symptoms, older adults and medical conditions, prepare your family and a detailed map stating the current status of the Coronavirus in the US.
CDC is responding to a pandemic of respiratory disease spreadingfrom person-to-person caused by a novel (new) coronavirus. The disease has been named "coronavirus disease 2019" (abbreviated "COVID-19"). This situation poses a serious public health risk. The federal government is working closely with state, local, tribal, and territorial partners, as well as public health partners, to respond to this situation. COVID-19 can cause mild to severe illness; most severe illness occurs in older adults.

Cochrane
Cochrane has started a special Collection entitled Coronavirus (COVID-19): evidence relevant to critical care at https://www.cochrane.org/special-collection-corona virus-covid-19-evidence-relevant-criticalcare. Cochrane is for anyone interested in using highquality information to make health decisions. Whether you are a doctor or nurse, patient or carer, researcher or funder, Cochrane evidence provides a powerful tool to enhance your healthcare knowledge and decision making. Cochrane has released a Special Collection: Coronavirus (COVID-19): evidence relevant to critical care, which is also available in Simplified Chinese, Farsi, French, Japanese, Bahasa Malaysia, and Spanish. News item available in German and Polish.

Elsevier
Elsevier has started its own Novel Coronavirus Information Center. Here you will find expert, curated information for the research and health community on novel coronavirus (COVID-19). All resources are free to access and include guidelines for clinicians and patients. There are variou sections for researchers, clinicians, patients etc. The page is live at https://www.elsevier.com/connect/coronavirus-infor Said Nadeem 10/13 mation-center.

The Lancet
The lancet has started a COVID-19 resource center at https://www.thelancet.com/coronavirus. To assist health workers and researchers working under challenging conditions to bring this outbreak to a close, The Lancet has created a Coronavirus Resource Centre. This resource brings together new 2019 novel coronavirus disease (COVID-19) content from across The Lancet journals as it is published. All of our COVID-19 content is free to access. This page provides informations about various editorials, comments, world report, correspondance, and an email for media queries.

The New England Journal of Medicine (NEJM)
NEJM is providing a collection of articles and other resources on the Coronavirus (Covid-19) outbreak, including clinical reports, management guidelines, and commentary at https://www.nejm.org/coronavirus. There are also many articles linked to the page with few lines of introduction.

Oxford University Press
Oxford University Press has create a page at https://academic.oup.com/journals/pages/coronaviru s?cc=us&lang=en& about the free access to OUP resources on coronavirus and related topics. The articles are provided by the journals published by the OUP and/or related companies mainly Clinical Infectious Diseases, Open Forum Infectious Diseases, Clinical Kidney Journal, Nephrology Dialysis Transplantation, Journal of Antimicrobial Chemotherapy etc. There are also articles provided by Oxfored Medicin Online.

PLOS Blogs
PLOS Blogs has started a blog on the novel coronavirus (2019-nCoV) outbreak at https://blogs.plos.org/plos/2020/01/novel-coronaviru s-2019-ncov-outbreak/. There is also another compain at this page where many companies has signed or promised to provide open access articles related to the Coronavirus COVID-19 at https://wellcome.ac.uk/press-release/sharing-researc h-data-and-findings-relevant-novel-coronaviruscovid-19-outbreak. Rapidly evolving healthcare emergencies necessitate the quick dissemination of research. The growing role of early-stage research, often referred to as preprints, was acknowledged in the Ebola and Zika virus outbreaks as a way of "accelerating the dissemination of scientific findings to support responses to infectious disease outbreaks". SSRN, Elsevier's world-leading platform devoted to the rapid worldwide dissemination of early-stage research, is committed to making coronavirus-related research available immediately. Research on SSRN is free to download and upload. It is important to note that these papers have not benefited from the pivotal role of peer-review, which validates and improves the quality of final published journal articles.

Signatories to the statement
Content is presented in the following categories:   In addition to the articles on this site related to the current outbreak, Wiley is also making a collection of journal articles and our book chapters on coronavirus research freely available to the global scientific community. On workdays, newly published articles are made free within 24 hours of publication. Articles published after 14:00 (EST) on Friday will be made free the following Monday.
In response to the call to action from OSTP and other governments, Wiley will start feeding content into PubMed Central as it comes in and licensing it to maximize discoverability and usability.